MastectomyMetastasisBiopsyER+ProgestinAdvocacyLymphoscintigraphyER-MultimodalityTherapyEGFR(epidermalgrowth factorreceptor)CyclophosphamideRaloxifeneChemotherapyCytostaticMethotrexateNeoadjuvantTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyMorpheaSclerosingAdenosisHormoneReplacementTherapyCachexiaOvarianSuppressionStagingBevacizumabMastodyniaPhyllodesTumorRadiotherapyBRCAGeneDisease-FreeSurvivalRateAdjuvantTherapyGuaranteedRenewableInsuranceCystACChemotherapyBenignPhyllodesTumorPARPInhibitorsPrecisionMedicineECOGScoreWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.GeneMutationMolecularBreastImagingRelapseBOCAOligometastases1 in 8womenLumpectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PalpationFlowCytometryFISHDimplingPagetDiseaseDiabeticMastopathyTamoxifenMetastaticBreastCancerDown-StagingBrachytherapyEvidencesuggests thatphysical activitymay reduce therisk of breastcancersMegestrolAcetateSERMOophorectomyKi-67RateCo-survivorCapecitabineCDK4/6InhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTumorGradeGeneticPredispositionTriplePositiveBreastCancerLumpApoptosisPathologicResponseBI-RADSAbsoluteRiskSelf-examinationLymphNodeStatusMultifocalTumorsMastalgiaGenomicTestingNeoplasmGeneticCounselingHER-2AromataseInhibitorsIn-situCarcinomaCheckpointInhibitorMastitisNodeNegativeNodePositiveDoseDenseTherapyAnastrozoleDefinitiveSurgeryAdenocarcinomaMRIGailModelEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEstrogenPI3KinaseInhibitorsIntraductalPapillomaRADFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FibroadenomaAyurvedaBreastCancerInvasiveBreastCancerImmunotherapyCalcificationsBreastTomosynthesisTyrosine-KinaseInhibitorLapatinibAntiemeticDoxorubicinAxillarySamplingChemopreventionAlopeciaExcisionalBiopsyEstradiollatissimusflapDocetaxelAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPalbociclibGermlineMutationmTORInhibitorsLiquidBiopsyCytotoxicTripleNegativeBreastCancerFamilyHistoryAntibodyTherapyHormoneReceptorStatusPaclitaxel5-FluorouracilCAMBilateralProphylacticMastectomyAngiogenesisEndometrialCancerLCISCMFChemotherapyHerceptinKappaEpsilonMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMastectomyMetastasisBiopsyER+ProgestinAdvocacyLymphoscintigraphyER-MultimodalityTherapyEGFR(epidermalgrowth factorreceptor)CyclophosphamideRaloxifeneChemotherapyCytostaticMethotrexateNeoadjuvantTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyMorpheaSclerosingAdenosisHormoneReplacementTherapyCachexiaOvarianSuppressionStagingBevacizumabMastodyniaPhyllodesTumorRadiotherapyBRCAGeneDisease-FreeSurvivalRateAdjuvantTherapyGuaranteedRenewableInsuranceCystACChemotherapyBenignPhyllodesTumorPARPInhibitorsPrecisionMedicineECOGScoreWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.GeneMutationMolecularBreastImagingRelapseBOCAOligometastases1 in 8womenLumpectomyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PalpationFlowCytometryFISHDimplingPagetDiseaseDiabeticMastopathyTamoxifenMetastaticBreastCancerDown-StagingBrachytherapyEvidencesuggests thatphysical activitymay reduce therisk of breastcancersMegestrolAcetateSERMOophorectomyKi-67RateCo-survivorCapecitabineCDK4/6InhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTumorGradeGeneticPredispositionTriplePositiveBreastCancerLumpApoptosisPathologicResponseBI-RADSAbsoluteRiskSelf-examinationLymphNodeStatusMultifocalTumorsMastalgiaGenomicTestingNeoplasmGeneticCounselingHER-2AromataseInhibitorsIn-situCarcinomaCheckpointInhibitorMastitisNodeNegativeNodePositiveDoseDenseTherapyAnastrozoleDefinitiveSurgeryAdenocarcinomaMRIGailModelEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEstrogenPI3KinaseInhibitorsIntraductalPapillomaRADFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FibroadenomaAyurvedaBreastCancerInvasiveBreastCancerImmunotherapyCalcificationsBreastTomosynthesisTyrosine-KinaseInhibitorLapatinibAntiemeticDoxorubicinAxillarySamplingChemopreventionAlopeciaExcisionalBiopsyEstradiollatissimusflapDocetaxelAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPalbociclibGermlineMutationmTORInhibitorsLiquidBiopsyCytotoxicTripleNegativeBreastCancerFamilyHistoryAntibodyTherapyHormoneReceptorStatusPaclitaxel5-FluorouracilCAMBilateralProphylacticMastectomyAngiogenesisEndometrialCancerLCISCMFChemotherapyHerceptinKappaEpsilonMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Mastectomy
  2. Metastasis
  3. Biopsy
  4. ER+
  5. Progestin
  6. Advocacy
  7. Lymphoscintigraphy
  8. ER-
  9. Multimodality Therapy
  10. EGFR (epidermal growth factor receptor)
  11. Cyclophosphamide
  12. Raloxifene
  13. Chemotherapy
  14. Cytostatic
  15. Methotrexate
  16. Neoadjuvant Therapy
  17. Women ages 40+ should have a clinical breast exam at least yearly
  18. Morphea
  19. Sclerosing Adenosis
  20. Hormone Replacement Therapy
  21. Cachexia
  22. Ovarian Suppression
  23. Staging
  24. Bevacizumab
  25. Mastodynia
  26. Phyllodes Tumor
  27. Radiotherapy
  28. BRCA Gene
  29. Disease-Free Survival Rate
  30. Adjuvant Therapy
  31. Guaranteed Renewable Insurance
  32. Cyst
  33. AC Chemotherapy
  34. Benign Phyllodes Tumor
  35. PARP Inhibitors
  36. Precision Medicine
  37. ECOG Score
  38. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  39. Gene Mutation
  40. Molecular Breast Imaging
  41. Relapse
  42. BOCA
  43. Oligometastases
  44. 1 in 8 women
  45. Lumpectomy
  46. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  47. Palpation
  48. Flow Cytometry
  49. FISH
  50. Dimpling
  51. Paget Disease
  52. Diabetic Mastopathy
  53. Tamoxifen
  54. Metastatic Breast Cancer
  55. Down-Staging
  56. Brachytherapy
  57. Evidence suggests that physical activity may reduce the risk of breast cancers
  58. Megestrol Acetate
  59. SERM
  60. Oophorectomy
  61. Ki-67 Rate
  62. Co-survivor
  63. Capecitabine
  64. CDK4/6 Inhibitors
  65. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  66. Tumor Grade
  67. Genetic Predisposition
  68. Triple Positive Breast Cancer
  69. Lump
  70. Apoptosis
  71. Pathologic Response
  72. BI-RADS
  73. Absolute Risk
  74. Self-examination
  75. Lymph Node Status
  76. Multifocal Tumors
  77. Mastalgia
  78. Genomic Testing
  79. Neoplasm
  80. Genetic Counseling
  81. HER-2
  82. Aromatase Inhibitors
  83. In-situ Carcinoma
  84. Checkpoint Inhibitor
  85. Mastitis
  86. Node Negative
  87. Node Positive
  88. Dose Dense Therapy
  89. Anastrozole
  90. Definitive Surgery
  91. Adenocarcinoma
  92. MRI
  93. Gail Model
  94. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  95. Estrogen
  96. PI3 Kinase Inhibitors
  97. Intraductal Papilloma
  98. RAD
  99. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  100. Fibroadenoma
  101. Ayurveda
  102. Breast Cancer
  103. Invasive Breast Cancer
  104. Immunotherapy
  105. Calcifications
  106. Breast Tomosynthesis
  107. Tyrosine-Kinase Inhibitor
  108. Lapatinib
  109. Antiemetic
  110. Doxorubicin
  111. Axillary Sampling
  112. Chemoprevention
  113. Alopecia
  114. Excisional Biopsy
  115. Estradiol
  116. latissimus flap
  117. Docetaxel
  118. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  119. Palbociclib
  120. Germline Mutation
  121. mTOR Inhibitors
  122. Liquid Biopsy
  123. Cytotoxic
  124. Triple Negative Breast Cancer
  125. Family History
  126. Antibody Therapy
  127. Hormone Receptor Status
  128. Paclitaxel
  129. 5-Fluorouracil
  130. CAM
  131. Bilateral Prophylactic Mastectomy
  132. Angiogenesis
  133. Endometrial Cancer
  134. LCIS
  135. CMF Chemotherapy
  136. Herceptin
  137. Kappa Epsilon
  138. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt